These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 27056726)
41. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats]. Tang BD; Zeng ZR; Hu PJ Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761 [TBL] [Abstract][Full Text] [Related]
42. Novel celecoxib analogues inhibit glial production of prostaglandin E2, nitric oxide, and oxygen radicals reverting the neuroinflammatory responses induced by misfolded prion protein fragment 90-231 or lipopolysaccharide. Villa V; Thellung S; Bajetto A; Gatta E; Robello M; Novelli F; Tasso B; Tonelli M; Florio T Pharmacol Res; 2016 Nov; 113(Pt A):500-514. PubMed ID: 27667770 [TBL] [Abstract][Full Text] [Related]
44. Bile modulates intestinal epithelial barrier function via an extracellular signal related kinase 1/2 dependent mechanism. Yang R; Harada T; Li J; Uchiyama T; Han Y; Englert JA; Fink MP Intensive Care Med; 2005 May; 31(5):709-17. PubMed ID: 15782315 [TBL] [Abstract][Full Text] [Related]
45. Co-administration of 3-Acetyl-11-Keto-Beta-Boswellic Acid Potentiates the Protective Effect of Celecoxib in Lipopolysaccharide-Induced Cognitive Impairment in Mice: Possible Implication of Anti-inflammatory and Antiglutamatergic Pathways. Sayed AS; El Sayed NS J Mol Neurosci; 2016 May; 59(1):58-67. PubMed ID: 26984336 [TBL] [Abstract][Full Text] [Related]
46. NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? Fornai M; Antonioli L; Colucci R; Pellegrini C; Giustarini G; Testai L; Martelli A; Matarangasi A; Natale G; Calderone V; Tuccori M; Scarpignato C; Blandizzi C J Pharmacol Exp Ther; 2014 Jan; 348(1):86-95. PubMed ID: 24135073 [TBL] [Abstract][Full Text] [Related]
47. Celecoxib enhances the anti-inflammatory effects of farnesylthiosalicylic acid on T cells independent of prostaglandin E(2) production. Mor A; Aizman E; Kloog Y Inflammation; 2012 Oct; 35(5):1706-14. PubMed ID: 22688643 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis. Ko CJ; Lan SW; Lu YC; Cheng TS; Lai PF; Tsai CH; Hsu TW; Lin HY; Shyu HY; Wu SR; Lin HH; Hsiao PW; Chen CH; Huang HP; Lee MS Oncogene; 2017 Aug; 36(32):4597-4609. PubMed ID: 28368394 [TBL] [Abstract][Full Text] [Related]
49. Cyclooxygenase-2 inhibitor inhibits hippocampal synaptic reorganization in pilocarpine-induced status epilepticus rats. Zhang HJ; Sun RP; Lei GF; Yang L; Liu CX J Zhejiang Univ Sci B; 2008 Nov; 9(11):903-15. PubMed ID: 18988310 [TBL] [Abstract][Full Text] [Related]
50. Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis. Hayakawa T; Fujiwara Y; Hamaguchi M; Sugawa T; Okuyama M; Sasaki E; Watanabe T; Tominaga K; Oshitani N; Higuchi K; Arakawa T Gut; 2006 Apr; 55(4):450-6. PubMed ID: 16210398 [TBL] [Abstract][Full Text] [Related]
51. Celecoxib, a cyclooxygenase-2 inhibitor, offers chemoprevention against reproductive and neurobehavioural abnormalities induced by atrazine in male Wistar rats. Kale OE; Oyesola TO; Raji FS Environ Toxicol Pharmacol; 2018 Mar; 58():84-97. PubMed ID: 29306822 [TBL] [Abstract][Full Text] [Related]
52. Decreased expression of E-cadherin and ZO-1 in the nasal mucosa of patients with allergic rhinitis: Altered regulation of E-cadherin by IL-4, IL-5, and TNF-alpha. Lee HJ; Kim B; Im NR; Lee DY; Kim HK; Lee SH; Lee HM; Lee SH; Baek SK; Kim TH Am J Rhinol Allergy; 2016 May; 30(3):173-8. PubMed ID: 27216347 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro. Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548 [TBL] [Abstract][Full Text] [Related]
54. The Beneficial Effects of P2X7 Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis. Tung HC; Lee FY; Wang SS; Tsai MH; Lee JY; Huo TI; Huang HC; Chuang CL; Lin HC; Lee SD PLoS One; 2015; 10(5):e0124654. PubMed ID: 25933224 [TBL] [Abstract][Full Text] [Related]
55. Chronic effects of celecoxib, a cyclooxygenase-2 inhibitor, cause enhanced alcohol-induced liver steatosis in rats. Bykov IL; Palmen M; Rainsford KD; Lindros KO Inflammopharmacology; 2006 Mar; 14(1-2):36-41. PubMed ID: 16835711 [TBL] [Abstract][Full Text] [Related]
56. Biocompatibility and intradiscal application of a thermoreversible celecoxib-loaded poly-N-isopropylacrylamide MgFe-layered double hydroxide hydrogel in a canine model. Willems N; Yang HY; Langelaan ML; Tellegen AR; Grinwis GC; Kranenburg HJ; Riemers FM; Plomp SG; Craenmehr EG; Dhert WJ; Papen-Botterhuis NE; Meij BP; Creemers LB; Tryfonidou MA Arthritis Res Ther; 2015 Aug; 17(1):214. PubMed ID: 26290179 [TBL] [Abstract][Full Text] [Related]
57. IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats. Zhao TY; Su LP; Ma CY; Zhai XH; Duan ZJ; Zhu Y; Zhao G; Li CY; Wang LX; Yang D BMC Gastroenterol; 2015 Jul; 15():77. PubMed ID: 26152281 [TBL] [Abstract][Full Text] [Related]
58. Ascorbic acid suppresses endotoxemia and NF-κB signaling cascade in alcoholic liver fibrosis in guinea pigs: a mechanistic approach. Abhilash PA; Harikrishnan R; Indira M Toxicol Appl Pharmacol; 2014 Jan; 274(2):215-24. PubMed ID: 24239723 [TBL] [Abstract][Full Text] [Related]
59. Moxibustion regulates inflammatory mediators and colonic mucosal barrier in ulcerative colitis rats. Ma TM; Xu N; Ma XD; Bai ZH; Tao X; Yan HC World J Gastroenterol; 2016 Feb; 22(8):2566-75. PubMed ID: 26937144 [TBL] [Abstract][Full Text] [Related]
60. Interleukin-1beta-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling. Gray T; Nettesheim P; Loftin C; Koo JS; Bonner J; Peddada S; Langenbach R Mol Pharmacol; 2004 Aug; 66(2):337-46. PubMed ID: 15266025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]